• PMO team

A great start of RTCure

Updated: Feb 27, 2018

After the very successful kick-off meeting in Stockholm the project is now up and running with a lot of enthusiasm. A big thank you for your efforts and your presence in Stockholm!


FACT SHEET​​

  • Place: Stockholm, Sweden

  • Date: 21-23 September, 2017

  • Number of participants: 69 participants

  • Objective: To discuss future work and to determine how to best achieve RTCure's goal, i.e. to be able to induce immune tolerance in RA

  • Programme & Results: We had a very appreciated scientific speed dating session were the academic partners and SMEs had the opportunity to meet the EFPIA partners one on one to find common interests and get to know each other better. Also, all partners got the chance to present their teams and expertise and their expectations with the RTCure project.


67 views
  • Follow us on Twitter

Follow us on Twitter:

The RTCure project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement no 777357. This joint undertaking receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA.

The communication reflects the author's view; neither IMI nor the European Union or EFPIA  are responsible for any use that may be made of the information contained herein.